Royal DSM N.V. has acquired Microbia Inc. in a bid to expand its position in specialty ingredients.


DSM plans to incorporate Microbia's research and development capabilities to support DSM's development of the natural carotenoids market. "The acquisition of Microbia represents a significant step for DSM in our strategy to accelerate our innovation activities in natural products and fermentation processes," said Leendert Staal, president and CEO of DSM Nutritional Products. "This acquisition allows us to expand our product portfolio as well as our research and development capabilities."